These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
5. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. Rothenburger M, Wichter T, Schmid C, Stypmann J, Tjan TD, Berendes E, Etz C, Pioux A, Löher A, Wenzelburger F, Drees G, Hoffmeier A, Breithardt G, Scheld HH. J Heart Lung Transplant; 2004 Oct 13; 23(10):1189-97. PubMed ID: 15477114 [Abstract] [Full Text] [Related]
10. NT-proBNP, IGF-I and survival in patients with chronic heart failure. Petretta M, Colao A, Sardu C, Scopacasa F, Marzullo P, Pivonello R, Fontanella L, de Caterina M, de Simone A, Bonaduce D. Growth Horm IGF Res; 2007 Aug 17; 17(4):288-96. PubMed ID: 17383209 [Abstract] [Full Text] [Related]
12. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure. Linzbach S, Samigullin A, Yilmaz S, Tsioga M, Zeiher AM, Spyridopoulos I. Am J Cardiol; 2009 Apr 15; 103(8):1128-33. PubMed ID: 19361601 [Abstract] [Full Text] [Related]
13. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R. J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981 [Abstract] [Full Text] [Related]
14. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E. Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998 [Abstract] [Full Text] [Related]
17. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP. J Am Coll Cardiol; 2005 May 17; 45(10):1667-71. PubMed ID: 15893185 [Abstract] [Full Text] [Related]
18. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center. Amir O, Paz H, Ammar R, Yaniv N, Schliamser JE, Lewis BS. Isr Med Assoc J; 2008 Feb 17; 10(2):109-12. PubMed ID: 18432021 [Abstract] [Full Text] [Related]
20. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease. Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA. Kidney Blood Press Res; 2009 Feb 17; 32(5):373-9. PubMed ID: 19887825 [Abstract] [Full Text] [Related] Page: [Next] [New Search]